Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study
NCT02485808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1879
Last updated 2019-01-15
Summary
The purpose of this study is to advance our understanding of people who experience urinary and bladder problems. We are interested in learning about people's experiences with urinary symptoms and how these symptoms will be managed. We want to understand the important differences among people and what factors affect urinary and bladder problems. After all of the information is collected, we will have a better understanding of how to improve the care and treatment for people who have urinary and bladder problems.
Conditions
- Lower Urinary Tract Symptoms
Interventions
- OTHER
-
None-observational
For surgical patients, follow-up assessments will occur 3 and 12 months after the surgery. For medical patients, follow-up assessments will occur 3 and 12 months after the baseline assessment.
- PROCEDURE
-
Magnetic Resonance Imaging (MRI)
One time MRI scanning session examining brain structure and function in a resting state and after water consumption.
- OTHER
-
Multimodal Automated Sensory Testing System
Pressure pain thresholds will be assess using computer-controlled pressures delivered by a device called the Multimodal Automated Sensory Testing System (MAST) device on to the subjects thumbnail bed.
- OTHER
-
Auditory Sensitivity Test
Subjects' sensitivity to sound will be evaluated using a series of sounds delivered by a standard audiometer device.
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - collaborator OTHER
- collaborator OTHER
- collaborator OTHER
-
University of Iowa
collaborator OTHER - collaborator OTHER
-
Washington University School of Medicine
collaborator OTHER -
Arbor Research Collaborative for Health
lead OTHER
Principal Investigators
-
Kevin P Weinfurt, PhD · Duke University
-
Claire Yang, MD · University of Washington
-
Robert M Merion, MD, FACS · Arbor Research Collaborative for Health - DCC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2018-04-30
- Completion
- 2018-05-31
Countries
- United States
Study Locations
More Related Trials
-
Trans-MAPP II Study of Urologic Chronic Pelvin Pain
NCT02898220 ·Status: COMPLETED
-
Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients
NCT01834391 ·Status: COMPLETED
-
RISE FOR HEALTH Study
NCT05365971 ·Status: COMPLETED
-
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
NCT05652023 ·Status: RECRUITING
-
Phenazopyridine for Confirmation of Ureteral Patency
NCT02424149 ·Status: COMPLETED ·Phase: NA
-
Evaluating UTI Diagnosis in Nursing Homes
NCT04815369 ·Status: WITHDRAWN
-
Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)
NCT02591901 ·Status: COMPLETED ·Phase: PHASE2
-
Host Response to Urinary Tract Infection in Women
NCT00642070 ·Status: COMPLETED
-
Developing a PROM for Recurrent Urinary Tract Infection
NCT05086900 ·Status: UNKNOWN
-
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
NCT01098279 ·Status: COMPLETED
-
EHR-integrated rUTI Texting Platform
NCT06035601 ·Status: COMPLETED ·Phase: NA
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
NCT06976125 ·Status: RECRUITING ·Phase: NA
-
NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis
NCT06128213 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
NCT04846803 ·Status: RECRUITING ·Phase: NA
-
COVID-19 Vaccines and the Development of New LUTS
NCT05582525 ·Status: COMPLETED
-
Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women
NCT03106103 ·Status: COMPLETED
-
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
NCT00704457 ·Status: COMPLETED
-
DIagnoSing Care hOme UTI Study
NCT05880329 ·Status: RECRUITING
-
Bladder Shaper Test
NCT04017000 ·Status: COMPLETED ·Phase: NA
-
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
NCT02591199 ·Status: TERMINATED ·Phase: PHASE2
-
Urology Database to Evaluate Clinical Information and Improve Patient Care.
NCT00376298 ·Status: COMPLETED
-
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
NCT03931408 ·Status: COMPLETED ·Phase: PHASE2
-
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
NCT05811377 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Quantitative Studies of Urinary Bladder Sensation
NCT00903435 ·Status: COMPLETED
-
Evaluating UTI Outcomes in at Risk Populations
NCT05385536 ·Status: COMPLETED